0.77 USD
↗ 0.01 (1.22%)AT CLOSE (11:59 AM EDT)
InMed Pharmaceuticals Inc. Common Shares
INMNASDAQ • USD
0.77
↘ 0.01 (0.83%)
POST MARKET (AS OF 04:15 PM EDT)
Post Market
AS OF 04:15 PM EDT
0.77
↘ 0.01 (0.83%)
Market: CLOSED
Open?$0.78
High?$0.78
Low?$0.75
Prev. Close?$0.76
Volume?41.0K
Avg. Volume?135.7K
VWAP?$0.76
Rel. Volume?0.30x
Bid / Ask
Bid?$0.72 × 1.3K
Ask?$0.77 × 700
Spread?$0.05
Midpoint?$0.74
Valuation & Ratios
Market Cap?2.6M
Shares Out?3.3M
Float?2.6M
Float %?89.2%
P/E Ratio?N/A
P/B Ratio?0.27
EPS?-$2.31
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?5.94Strong
Quick Ratio?5.30Strong
Cash Ratio?4.70Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score100/100
P/E?N/A▾
P/B?0.27CHEAP▾
P/S?0.57CHEAP▾
P/FCF?N/A▾
EV/EBITDA?0.6CHEAP▾
EV/Sales?-0.98CHEAP▾
Returns & Efficiency
ROE?-79.9%WEAK▾
ROA?-68.5%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$-4403005
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.
Employees
13
Market Cap
2.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-11-10
Address
1445-885 WEST GEORGIA ST.
VANCOUVER, A1 V6C 3E8
Phone: (604) 669-7207
VANCOUVER, A1 V6C 3E8
Phone: (604) 669-7207